These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30849641)

  • 1. Metformin sensitizes endometrial cancer cells to progestin by targeting TET1 to downregulate glyoxalase I expression.
    Jiang Y; Chen X; Wei Y; Feng Y; Zheng W; Zhang Z
    Biomed Pharmacother; 2019 May; 113():108712. PubMed ID: 30849641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin reverses progestin resistance in endometrial cancer cells by downregulating GloI expression.
    Zhang Z; Dong L; Sui L; Yang Y; Liu X; Yu Y; Zhu Y; Feng Y
    Int J Gynecol Cancer; 2011 Feb; 21(2):213-21. PubMed ID: 21270604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin sensitizes endometrial cancer cells to chemotherapy by repressing glyoxalase I expression.
    Dong L; Zhou Q; Zhang Z; Zhu Y; Duan T; Feng Y
    J Obstet Gynaecol Res; 2012 Aug; 38(8):1077-85. PubMed ID: 22540333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin sensitizes endometrial cancer cells to chemotherapy through IDH1-induced Nrf2 expression via an epigenetic mechanism.
    Bai M; Yang L; Liao H; Liang X; Xie B; Xiong J; Tao X; Chen X; Cheng Y; Chen X; Feng Y; Zhang Z; Zheng W
    Oncogene; 2018 Oct; 37(42):5666-5681. PubMed ID: 29921847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brusatol sensitizes endometrial hyperplasia and cancer to progestin by suppressing NRF2-TET1-AKR1C1-mediated progestin metabolism.
    Hu M; Sun D; Yu J; Fu Y; Qin Z; Huang B; Zhang Q; Chen X; Wei Y; Zhu H; Wang Y; Feng Y; Zheng W; Liao H; Li J; Wu S; Zhang Z
    Lab Invest; 2022 Dec; 102(12):1335-1345. PubMed ID: 36038734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of ten-eleven translocation 1 (TET1) expression as a diagnostic and prognostic biomarker of endometrial carcinoma.
    Liu NT; Perng CL; Chou YC; Ko PS; Lin YJ; Lin YC; Chang CC; Wang YC; Shang HS; Chao TK
    PLoS One; 2021; 16(11):e0259330. PubMed ID: 34731191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-191 regulates endometrial cancer cell growth via TET1-mediated epigenetic modulation of APC.
    Yang C; Ota-Kurogi N; Ikeda K; Okumura T; Horie-Inoue K; Takeda S; Inoue S
    J Biochem; 2020 Jul; 168(1):7-14. PubMed ID: 32003827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TET1-GPER-PI3K/AKT pathway is involved in insulin-driven endometrial cancer cell proliferation.
    Xie BY; Lv QY; Ning CC; Yang BY; Shan WW; Cheng YL; Gu C; Luo XZ; Zhang ZB; Chen XJ; Xi XW; Feng YJ
    Biochem Biophys Res Commun; 2017 Jan; 482(4):857-862. PubMed ID: 27889612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NrCAM secreted by endometrial stromal cells enhances the progestin sensitivity of endometrial cancer cells through epigenetic modulation of PRB.
    Cheng Y; Xie L; Xu Z; Hao M; Yang B; Shan W; Wang Y; Lv Q; Chen X
    Cancer Gene Ther; 2022 Oct; 29(10):1452-1462. PubMed ID: 35388173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockage of Glyoxalase I Inhibits Colorectal Tumorigenesis and Tumor Growth via Upregulation of STAT1, p53, and Bax and Downregulation of c-Myc and Bcl-2.
    Chen Y; Fang L; Zhang J; Li G; Ma M; Li C; Lyu J; Meng QH
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28282916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of progestin resistance in endometrial precancer/cancer through Nrf2-AKR1C1 pathway.
    Wang Y; Wang Y; Zhang Z; Park JY; Guo D; Liao H; Yi X; Zheng Y; Zhang D; Chambers SK; Zheng W
    Oncotarget; 2016 Mar; 7(9):10363-72. PubMed ID: 26824415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect and regulation of metformin on endometrial carcinoma subline of progestin-resistance].
    Niu YJ; Shi HR; Xie Y
    Zhonghua Fu Chan Ke Za Zhi; 2016 Feb; 51(2):135-40. PubMed ID: 26917483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin: a potential novel endometrial cancer therapy.
    Mu N; Wang Y; Xue F
    Int J Gynecol Cancer; 2012 Feb; 22(2):181. PubMed ID: 22274313
    [No Abstract]   [Full Text] [Related]  

  • 14. Mechanisms involved in the evolution of progestin resistance in human endometrial hyperplasia--precursor of endometrial cancer.
    Wang S; Pudney J; Song J; Mor G; Schwartz PE; Zheng W
    Gynecol Oncol; 2003 Feb; 88(2):108-17. PubMed ID: 12586588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TET1 inhibits EMT of ovarian cancer cells through activating Wnt/β-catenin signaling inhibitors DKK1 and SFRP2.
    Duan H; Yan Z; Chen W; Wu Y; Han J; Guo H; Qiao J
    Gynecol Oncol; 2017 Nov; 147(2):408-417. PubMed ID: 28851501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of TET1 regulating MGMT on chemotherapy resistance of oral squamous cell carcinoma stem cells.
    Wang W; Li X; Wang F; Sun XY
    J Cell Biochem; 2018 Jan; 119(1):723-735. PubMed ID: 28643947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Research of the influence and mechanism about metformin on the proliferation of differentiated endometrial carcinoma cells].
    Wang J; Shi H; Xie Y; Peng Z
    Zhonghua Fu Chan Ke Za Zhi; 2015 Sep; 50(9):685-91. PubMed ID: 26675396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic ethanol-mediated hepatocyte apoptosis links to decreased TET1 and 5-hydroxymethylcytosine formation.
    Ji C; Nagaoka K; Zou J; Casulli S; Lu S; Cao KY; Zhang H; Iwagami Y; Carlson RI; Brooks K; Lawrence J; Mueller W; Wands JR; Huang CK
    FASEB J; 2019 Feb; 33(2):1824-1835. PubMed ID: 30188753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of TET1 facilitates DLD1 colon cancer cell migration via H3K27me3-mediated down-regulation of E-cadherin.
    Zhou Z; Zhang HS; Liu Y; Zhang ZG; Du GY; Li H; Yu XY; Huang YH
    J Cell Physiol; 2018 Feb; 233(2):1359-1369. PubMed ID: 28513825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxyurea promotes TET1 expression and induces apoptosis in osteosarcoma cells.
    Teng S; Ma C; Yu Y; Yi C
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30988069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.